[{"Assets_0_Q3_USD":255270000.0,"CommonStockSharesOutstanding_0_Q3_shares":27178230.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-20347000.0,"NetIncomeLoss_1_Q3_USD":-68377000.0,"NetIncomeLoss_3_Q3_USD":-35219000.0,"StockholdersEquity_0_Q3_USD":68512000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]